Table 2 Baseline tertiles of serum liver fibrosis markers based on the development of hepatic decompensation during follow-up
From: Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Serum liver fibrosis markers | Range | No decompensation, (n = 619) | Decompensation, (n = 69) | P value |
|---|---|---|---|---|
HA | (ng/mL) |  |  | < 0.001 |
Tertile 1, n = 229 | 30.0–97.0 | 220 (35.5) | 9 (13.0) |  |
Tertile 2, n = 229 | 97.0-220.0 | 209 (33.8) | 20 (29.0) |  |
Tertile 3, n = 230 | 220.0-6287.0 | 190 (30.7) | 40 (58.0) |  |
LN | (ng/mL) |  |  | < 0.001 |
Tertile 1, n = 229 | 15.0–91.0 | 213 (34.4) | 16 (23.2) |  |
Tertile 2, n = 229 | 91.0-100.0 | 216 (34.9) | 13 (18.8) |  |
Tertile 3, n = 230 | 100.0-353.0 | 190 (30.7) | 40 (58.0) |  |
CIV | (ng/mL) |  |  | < 0.001 |
Tertile 1, n = 229 | 10.0–65.0 | 226 (36.5) | 3 (4.3) |  |
Tertile 2, n = 229 | 65.0-108.0 | 205 (33.1) | 24 (34.8) |  |
Tertile 3, n = 230 | 108.0-612.0 | 188 (30.4) | 42 (60.9) |  |
PIIINP | (ng/mL) | Â | Â | 0.014 |
Tertile 1, n = 229 | 2.0–8.0 | 216 (34.9) | 13 (18.8) |  |
Tertile 2, n = 229 | 8.0–12.0 | 202 (32.6) | 27 (39.1) |  |
Tertile 3, n = 230 | 12.0–61.0 | 201 (32.5) | 29 (42.0) |  |